Medicine

'The Indira Gandhi of AIIMS': Sneh Bhargava's memoir is a compelling read

From hospital politics and clashing egos to difficult politicians and controversial appointments - Sneh Bhargava's memoir lays bare the inner workings of Aiims

'None of them are really doctors': Liver Doc takes on Vidit Gujrathi on X

Modern medicine Vs Ayurveda: new feud between Chess grandmaster Vidit Gujrathi and Dr Cyriac Abby Philips on Doctor's Day ignites controversy on X

Genomic testing sees sharp uptake in India, now growing beyond metros

With 18 per cent CAGR, India's genomic diagnostics market is expanding into Tier 2 and 3 cities as affordability, cancer screening, and personalised care fuel adoption

T'gana mental health institute: 1 dead, 70 complain of vomiting, diarrhoea

One person died and around 70 others suffered from vomiting and diarrhoea at the Telangana government's Institute of Mental Health (IMH) here, officials said. The incident occurred on Tuesday, prompting an investigation into it. The patient who died was found unresponsive on Tuesday morning. Despite efforts by medical staff on duty to revive him with CPR, he was later declared dead at the state-run Osmania General Hospital (OGH), Hyderabad District Collector Anudeep Durishetty, who visited the IMH, told reporters. Nearly 70 other patients have reported vomiting and diarrhoea. Two patients whose blood pressure was low were admitted to the OGH and their condition was not serious, he said. The remaining patients were under observation in the mental hospital and a special team of doctors has been called to attend to them. All the patients are stable, he said. The district collector said water samples from the source in the IMH were sent to the state government's Institute of Prevent

12 common cancer myths busted: What doctors say you must stop believing

Fact-check Friday: Doctors debunk persistent cancer myths-from sugar and deodorants to breast surgery and mobile phones-that often mislead patients, delay diagnosis, and derail treatment decisions

Will doorstep medicine delivery end? Govt panel set to take a call soon

India's Drugs Technical Advisory Board will review the continuation of home medicine delivery, following objections from chemists' body AIOCD, which cites misuse by online platforms

Zydus, Lupin shares fall over US court ruling in Myrbetriq patent case

Companies say they are in process of assessing impact of order on operations

Ayush-approved medicines exempt from extra safety trials in research: ICMR

With growing global interest in holistic and personalised medicine, it is observed that ethical and regulatory clarity is essential to ensure the credibility and efficacy of integrative approaches

Amgen opens $200 million technology and innovation hub in Hyderabad

The facility, which occupies approximately 524,000 square feet across two towers in HITEC City, will focus on harnessing AI, data science, and digital innovation to accelerate research and development

Medino's: India's Hyperlocal 30-Minute Medicine Delivery & Healthcare Platform

.

New study links paracetamol to several side effects among senior citizens

Paracetamol, a common over-the-counter medication, may increase the risk of gastrointestinal, heart- and kidney-related complications among adults aged 65 and above, a new study has found. Taken commonly for treating mild-to-moderate fever, paracetamol is also the first drug recommended for treating osteoarthritis -- a chronic condition causing pain, stiffness and swelling in the joints due to wear-and-tear -- as it is considered effective, relatively safe and accessible. However, some studies have provided evidence to contest the effectiveness of paracetamol in relieving pain while others have shown increased risks of gastrointestinal side effects, such as ulcers and bleeding, from prolonged use. The latest study, conducted by researchers from the University of Nottingham, UK, found that paracetamol use was linked to a 24 per cent and 36 per cent increase in risk of peptic ulcer bleeding (bleeding due to ulcer in the digestive tract) and lower gastrointestinal bleeding, ...

Indian pharma market registers over 5% growth in Sept 2024: Pharmarack

This comes even as the IPM registered a negative unit growth of -2.3 per cent, with only anti-diabetic and urology therapy segments recording significant unit growth of 3.1 per cent and 5.4 per cent

India's medicine exports to US, Italy on the rise: Commerce ministry

With the government focusing on boosting domestic manufacturing of pharmaceutical products, India's medicine and antibiotics exports have started gaining significant market share in the US. According to the commerce ministry data, India is the third largest import source of 'medicine put up for retail sale' for the US. The top two are Ireland and Switzerland. In 2023, the country exported these medicines worth USD 9 billion as against 7.33 billion in 2022. With this increase in the shipments, India's share went up to 13.1 per cent in 2023 from 10.08 per cent in 2022. Share of the top exporter Ireland fell to 13.85 per cent in 2023 from 17.18 per cent in 2022 because its sales in the US went down to USD 9.5 billion in 2023 from USD 12.5 billion in 2022. The second biggest exporter Switzerland also saw its share decline to 13.7 per cent last year from 17.4 per cent in 2022. Similarly, India has increased its share among exporters of antibiotics in the Italian market. It is ranked 10

Alembic Pharma gets approval from US FDA to market generic medication

Alembic Pharmaceuticals on Tuesday said it has received approval from the US health regulator to market a generic product indicated for prophylaxis of deep vein thrombosis. The company has received approval from the US Food and Drug Administration (USFDA) to market Dabigatran Etexilate Capsules (110 mg), the drug firm said in a regulatory filing. Dabigatran Etexilate Capsules are indicated for prophylaxis of deep vein thrombosis and pulmonary embolism following hip replacement surgery. The approved product is therapeutically equivalent to Boehringer Ingelheim Pharmaceuticals Inc's Pradaxa Capsules (110 mg). The company said it now has a cumulative total of 211 ANDA (abbreviated new drug application) approvals from the USFDA. Shares of the company on Tuesday closed 3.17 per cent down at Rs 1,076 apiece on the BSE.

Doctors not mandated to inform patients on drug side effects: Delhi HC

Delhi High Court dismissed a public interest litigation that sought to enforce the compulsory disclosure of drug side effects by doctors to the patients

World Homeopathy Day 2024: All about Homoeopathy and its benefits

The target of homoeopathy is to address and to give therapy the whole of an individual, including their character, way of life, hereditary predispositions, and disease history

Uttar Pradesh government eyes 10-12% share in India's pharma sector

UP has signed memorandums of understanding with more than 80 CSIR and DRDO labs for research and development on affordable drugs

Cipla introduces drone-powered critical medicine delivery in Himachal

Drug major Cipla on Tuesday said it has introduced drone-powered deliveries of critical medicines for hospitals and pharmacies in Himachal Pradesh in partnership with Sky Air Mobility. The Mumbai-based firm aims to deliver medicines for cardiac, respiratory and other essential chronic therapies as part of the initiative. The use of drones will support on-time deliveries of the company's medicines to chemists and clinics in remote areas while minimising risks such as delays, temperature excursions affecting cold chain products, and roadside accidents, Cipla said in a statement. "As we accelerate our digital agenda across all functions, implementing drone-powered distribution enhances our supply chain resilience, strengthens connects with channel partners, helps us stay future ready and maintain reliable, prompt delivery of our trusted high-quality drugs to stockists and patients in the region," Cipla Global Supply Chain Head Swapn Malpani said. The drug firm said it also aims to sca

Celebrating India's emergence as a global leader in traditional medicine

Collaboration with WHO in establishing the Global Centre for Traditional Medicine underscores the country's commitment to traditional medicine

Abbott India recalls batches of Antacid Digene gel

In its letter, the DCGI warned that Digene may be unsafe and its use may result in adverse reaction